Please login to the form below

Not currently logged in
Email:
Password:

HTA

This page shows the latest HTA news and features for those working in and with pharma, biotech and healthcare.

2018 by Darwin

2018 by Darwin

As failed launches slow uptake and HTA rejections show us, a business model that has most of the costs of innovation but delivers few of its benefits is usually selected against

Latest news

  • Transforming access in rare diseases Transforming access in rare diseases

    Project HERCULES is a unique initiative set to radically improve the way evidence is generated for HTA submissions. ... history of the disease and developing a new quality of life metric, which is essential in cost-utility based HTA processes.

  • Duchenne UK and pharma partner pilot data-sharing HTA approach Duchenne UK and pharma partner pilot data-sharing HTA approach

    Duchenne UK and pharma partner pilot data-sharing HTA approach. Pfizer, Roche and PTC Therapeutics are among those participating in Project Hercules. ... HTA agencies can struggle with decisions in the absence of a solid evidence base, be that data on

  • EMA forges closer ties with HTA umbrella group EMA forges closer ties with HTA umbrella group

    EMA forges closer ties with HTA umbrella group. Agrees joint work plan with the European Network for Health Technology Assessment. ... introduced tool to try to standardise the assessment process for new medicinal products and avoid duplicating work by

  • MHRA joins Instagram as part of Yellow Card drive MHRA joins Instagram as part of Yellow Card drive

    In joining Instagram, where it is@mhragovuk, the MHRA follows in the footsteps of England and Wales’HTA body NICE(@nicecomms), which launched on the channel at the beginning of this

  • Reading the signals Reading the signals

    When we deforest an area, put carbon dioxide into the atmosphere or change an HTA methodology, we can predict the consequences with limited confidence and then only in the short term.

More from news
Approximately 35 fully matching, plus 150 partially matching documents found.

Latest Intelligence

  • The valuable brand The valuable brand

    If you need evidence of this, consider how few launches achieve their goals, the frequent rejection of new products by HTAs or the increasing price pressure faced by even successful brands.

  • Drug pricing

    Healthcare terms - Drug pricing.

  • Medical education

    Healthcare terms - Medical education.

  • Market access

    Healthcare terms - Market access.

  • The gold standard of scientific evidence The gold standard of scientific evidence

    Because of the perceived quality of clinical trials data, RCT data is used in most health technology assessment (HTA) appraisals around the world; in 2015, 90% of CADTH appraisals, 80% of

More from intelligence
Approximately 14 fully matching, plus 49 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 5 fully matching, plus 20 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics